IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD.

JCI Insight · 2022 · PMC9462491 · PMID 35763349

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

TMφ from COPD subjects displayed a nonsignificant trend toward increased IL-36G expression in cells from smokers and COPD subjects compared with controls ( Figure 2A ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.